| RS1267599270 |
DNAH9
|
Health Risk |
Pathogenic |
Ciliary dyskinesia, primary |
| RS1267604574 |
KIF1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 30, Neuropathy |
| RS1267615713 |
HADHA
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial trifunctional protein deficiency, Long chain 3-hydroxyacyl-CoA dehydrogenase deficiency |
| RS1267623393 |
BSND
|
Health Risk |
Pathogenic |
— |
| RS1267623765 |
ARSB
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis type 6, Mucopolysaccharidosis type 6 |
| RS1267658847 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Long QT syndrome |
| RS1267681596 |
MCOLN1
|
Health Risk |
Likely pathogenic |
Mucolipidosis type IV, Mucolipidosis type IV |
| RS1267688094 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1267712523 |
WT1
|
Health Risk |
Pathogenic |
Wilms tumor 1, 11p partial monosomy syndrome |
| RS1267718786 |
DNAAF2
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, DNAAF2-related disorder |
| RS1267721327 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS1267739726 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS1267751619 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 6, WFS1-Related Spectrum Disorders |
| RS1267757855 |
CYP1B1
|
Health Risk |
Likely pathogenic |
Anterior segment dysgenesis 6, Anterior segment dysgenesis 6 |
| RS1267759029 |
MLH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Malignant tumor of breast |
| RS1267766480 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2J, Dilated cardiomyopathy 1G |
| RS1267767301 |
MESP2
|
Health Risk |
Pathogenic |
— |
| RS1267791852 |
GALNS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS1267792511 |
PKHD1
|
Health Risk |
Likely pathogenic |
Polycystic kidney disease 4, Polycystic kidney disease 4 |
| RS1267795586 |
DSG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS1267805674 |
FKRP
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5 |
| RS1267810339 |
SGCD
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2F, Dilated cardiomyopathy 1L |
| RS1267819026 |
PHYH
|
Health Risk |
Pathogenic |
Phytanic acid storage disease, Phytanic acid storage disease |
| RS1267827826 |
MANBA
|
Health Risk |
Pathogenic |
Beta-D-mannosidosis, Beta-D-mannosidosis |
| RS1267837624 |
NPHS1
|
Health Risk |
Pathogenic |
— |
| RS1267839034 |
COL4A3
|
Health Risk |
Pathogenic |
— |
| RS1267845940 |
CACNA1C
|
Health Risk |
Conflicting classifications of pathogenicity |
CACNA1C-related disorder, Long QT syndrome |
| RS1267858785 |
RAD50
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1267868260 |
MYO15A
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS1267883785 |
DNAJC30
|
Health Risk |
Pathogenic |
Leber-like hereditary optic neuropathy, autosomal recessive 1 |
| RS1267947462 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1267970567 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1267995796 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
7 conditions, Epidermolysis bullosa dystrophica |
| RS1268006720 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1268011878 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type I, Osteogenesis imperfecta type I |
| RS1268038830 |
COL4A2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1268045311 |
GJB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Nonsyndromic genetic hearing loss, Nonsyndromic genetic hearing loss |
| RS1268051204 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Idiopathic Pulmonary Fibrosis, Dyskeratosis congenita |
| RS1268058356 |
PHKB
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IXb, Glycogen storage disease IXb |
| RS1268065530 |
DNAH1
|
Health Risk |
Pathogenic |
Spermatogenic failure 18, Ciliary dyskinesia |
| RS1268066075 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary breast ovarian cancer syndrome |
| RS1268066804 |
DYNC2H1
|
Health Risk |
Likely pathogenic |
Asphyxiating thoracic dystrophy 3, Asphyxiating thoracic dystrophy 3 |
| RS1268082439 |
ADSL
|
Health Risk |
Pathogenic |
Adenylosuccinate lyase deficiency, Adenylosuccinate lyase deficiency |
| RS1268089519 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1268133978 |
BRCA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary breast ovarian cancer syndrome, Hereditary cancer-predisposing syndrome |
| RS1268140508 |
USH2A
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 2A, Retinitis pigmentosa 39 |
| RS1268159078 |
VWF
|
Health Risk |
Pathogenic |
von Willebrand disease type 1, von Willebrand disease type 1 |
| RS1268159081 |
CCR2
|
Health Risk |
Pathogenic |
Cystic disease of lung, Cystic disease of lung |
| RS1268163857 |
TUBGCP6
|
Health Risk |
Pathogenic |
— |
| RS1268176383 |
ABCD1
|
Health Risk |
Likely pathogenic |
Adrenoleukodystrophy, Adrenoleukodystrophy |
| RS1268187387 |
CFAP410
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1268191908 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1268194684 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS1268200083 |
DYRK1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, DYRK1A-related intellectual disability syndrome |
| RS1268207836 |
EBF3
|
Health Risk |
Likely pathogenic |
Hypotonia, ataxia |
| RS1268227280 |
WRN
|
Health Risk |
Pathogenic |
Werner syndrome, Werner syndrome |
| RS1268230987 |
DUOX2
|
Health Risk |
Likely pathogenic |
— |
| RS1268237441 |
AICDA
|
Health Risk |
Pathogenic |
Hyper-IgM syndrome type 2, Hyper-IgM syndrome type 2 |
| RS1268264761 |
ADSL
|
Health Risk |
Likely pathogenic |
Adenylosuccinate lyase deficiency, Adenylosuccinate lyase deficiency |
| RS1268277078 |
STRADA
|
Health Risk |
Pathogenic |
Polyhydramnios, megalencephaly |
| RS1268280072 |
TMEM127
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary pheochromocytoma and paraganglioma |
| RS1268293635 |
MPI
|
Health Risk |
Conflicting classifications of pathogenicity |
MPI-congenital disorder of glycosylation, MPI-congenital disorder of glycosylation |
| RS1268304692 |
COL4A3
|
Health Risk |
Likely pathogenic |
Alport syndrome, Alport syndrome |
| RS1268307330 |
LCA5
|
Health Risk |
Pathogenic |
Leber congenital amaurosis 5, Leber congenital amaurosis 5 |
| RS1268309894 |
NBAS
|
Health Risk |
Pathogenic/Likely pathogenic |
Short stature-optic atrophy-Pelger-Huët anomaly syndrome, Infantile liver failure syndrome 2 |
| RS1268310821 |
MYH2
|
Health Risk |
Likely pathogenic |
Myopathy, proximal |
| RS1268314487 |
NDUFS7
|
Health Risk |
Likely pathogenic |
— |
| RS1268330519 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiovascular phenotype |
| RS1268362518 |
DSG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Arrhythmogenic right ventricular dysplasia 10 |
| RS1268377224 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS1268405497 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Connective tissue disorder, Adams-Oliver syndrome 5 |
| RS1268417773 |
NFIB
|
Health Risk |
Pathogenic |
— |
| RS1268424543 |
ACAT1
|
Health Risk |
Pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS1268440347 |
GALE
|
Health Risk |
Pathogenic/Likely pathogenic |
UDPglucose-4-epimerase deficiency, Thrombocytopenia 13 |
| RS1268442199 |
DSG1
|
Health Risk |
Pathogenic |
— |
| RS1268443604 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS1268456443 |
TBCK
|
Health Risk |
Pathogenic |
— |
| RS1268475752 |
DOK7
|
Health Risk |
Likely pathogenic |
Fetal akinesia deformation sequence 1, Congenital myasthenic syndrome 10 |
| RS1268475945 |
CHRNE
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome 4A, Congenital myasthenic syndrome 4A |
| RS1268481547 |
SPG11
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia 11, Hereditary spastic paraplegia 11 |
| RS1268482591 |
FAH
|
Health Risk |
Pathogenic |
Tyrosinemia type I, Tyrosinemia type I |
| RS1268486835 |
CFI
|
Health Risk |
Conflicting classifications of pathogenicity |
Atypical hemolytic-uremic syndrome, Atypical hemolytic-uremic syndrome |
| RS1268491295 |
FANCC
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia complementation group C, Fanconi anemia |
| RS1268502139 |
CLN5
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 5, Neuronal ceroid lipofuscinosis |
| RS1268506326 |
EGFR
|
Health Risk |
Conflicting classifications of pathogenicity |
EGFR-related lung cancer, Hereditary cancer-predisposing syndrome |
| RS1268507778 |
GPR179
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1268519003 |
ASL
|
Health Risk |
Pathogenic |
Argininosuccinate lyase deficiency, Argininosuccinate lyase deficiency |
| RS1268541922 |
LAMB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, LAMB2-related infantile-onset nephrotic syndrome |
| RS1268561604 |
JAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic dilatation, Scoliosis |
| RS1268572514 |
PTCH1
|
Health Risk |
Pathogenic |
Gorlin syndrome, Basal cell nevus syndrome 1 |
| RS1268592638 |
ABCC6
|
Health Risk |
Pathogenic |
— |
| RS1268594965 |
DYSF
|
Health Risk |
Pathogenic |
DYSF-related disorder, Autosomal recessive limb-girdle muscular dystrophy |
| RS1268625226 |
SPAST
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 4, Hereditary spastic paraplegia 4 |
| RS1268649558 |
ALK
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuroblastoma, susceptibility to |
| RS1268657053 |
STAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1268667021 |
RELA
|
Health Risk |
Pathogenic |
— |
| RS1268674934 |
LZTR1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1268678201 |
GUSB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis type 7, Mucopolysaccharidosis type 7 |
| RS1268679971 |
LMOD3
|
Health Risk |
Pathogenic |
Nemaline myopathy 10, Nemaline myopathy 10 |
| RS1268684924 |
PTRH2
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurologic, endocrine |